Administered once weekly via subcutaneous or parenteral routes, Survodutide acts through the activation of the glucagon-like peptide 1 receptor (GLP-1R). This receptor-mediated mechanism plays a crucial role in its potential therapeutic applications for metabolic and liver diseases.
Survodutide 10mg
$125.00
Details:
Survodutide (BI-456906) is currently under investigation for its efficacy in treating renal failure, non-alcoholic steatohepatitis (NASH), liver fibrosis, type 2 diabetes, and obesity.
Reviews
Clear filtersThere are no reviews yet.